AI-generated summary
This randomized trial compared photobiomodulation alone with photobiomodulation plus the FITOPROT herbal mouthwash in patients with head and neck cancer receiving radiotherapy. The authors report no difference in oral mucositis degree between the two groups, with radiotherapy dose significantly affecting mucositis, and they describe limited effects of FITOPROT on preventing severe mucositis.
- Who or what was studied
- Patients with head and neck cancer receiving radiotherapy
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The abstract reports only two small intervention groups (25 and 27 patients) and describes FITOPROT's effects as limited and associated with, not proven to cause, fewer severe cases.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Power
- 25 mW
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Oral mucositis, Trial registration, Wavelength, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.